Plain-English translation of NCT07402161 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking for better, easier ways to identify Alzheimer's disease in its earliest stages—when people start noticing memory problems but standard tests haven't picked up significant changes yet. Researchers will use blood tests, brain imaging, memory tests, and brain-wave recordings to find patterns that predict who has biological signs of Alzheimer's disease, even before symptoms become obvious.
Right now, the most accurate tests for early Alzheimer's are expensive, hard to access, or invasive (like spinal taps). This study aims to develop simpler, more affordable screening tools that doctors can use in regular clinics to catch Alzheimer's early—when new treatments might work best.
You likely qualify if…
You likely don't qualify if…
As a participant, you would complete memory and thinking tests, provide blood samples for biomarker analysis, possibly have a brain MRI scan, and complete an electroencephalogram (EEG)—a simple, non-invasive test that records brain electrical activity. The study will compare your results with advanced brain imaging and spinal fluid tests to see which accessible tests best predict early Alzheimer's disease. The exact number of visits and timeline isn't specified, but the research team will work with you throughout the study.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Italy